APA aipamena

Kushner, B. H., Cheung, I. Y., Modak, S., Basu, E. M., Roberts, S. S., & Cheung, N. (2018). Humanized 3F8 Anti-G(D2) Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial. JAMA Oncol.

Chicago Style aipamena

Kushner, Brian H., Irene Y. Cheung, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts, and Nai-Kong Cheung. "Humanized 3F8 Anti-G(D2) Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial." JAMA Oncol 2018.

MLA aipamena

Kushner, Brian H., et al. "Humanized 3F8 Anti-G(D2) Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial." JAMA Oncol 2018.